Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Capital Expenditures (2025)

Mereo BioPharma (MREO) has disclosed Capital Expenditures for 1 consecutive years, with $20000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to $20000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $20000.0, a N/A change, with the full-year FY2022 number at $13000.0, down 98.2% from a year prior.
  • Capital Expenditures was $20000.0 for Q1 2025 at Mereo BioPharma.
  • In the past five years, Capital Expenditures ranged from a high of $20000.0 in Q1 2025 to a low of $20000.0 in Q1 2025.